Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Systematic review and meta-analysis of 34 studies (983 438 adult cancer survivors) assessing 27 cardiovascular risk scores: about one-third of model-outcome evaluations had AUC ≥0.70; performance was better in breast cancer and substantially poorer in haematologic malignancies.
Meta-analysisn = 983,438
Kazemian et al. Cardiovascular risk-prediction models in cancer survivors: a meta-analysisSystematic review of 7 cohort or cross-sectional studies (109 365 participants): lower rest-activity rhythm amplitude was associated with higher cardiovascular (HR 1.50) and all-cause mortality (HR 1.46), and greater fragmentation with all-cause mortality (HR 1.05).
Meta-analysisn = 109,365
Chang et al. Association Between Rest-Activity Rhythm and Cardiovascular Disease, Cardiovascular Mortality, and All-Cause Mortality: A Systematic Review and Meta-AnalysisIndividual-participant meta-analysis of 84,128 TB contacts with infection: preventive treatment cut 1-year TB risk in medium- and low-burden settings (HR 0·14 and 0·21) with long-lasting protection, but not significantly in high-burden settings (HR 0·57, 95% CI 0·31–1·07).
Meta-analysisn = 84,128
Linde et al. Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysisMeta-analysis of 37 studies (N=69,572): impulsivity was associated with adolescent non-suicidal self-injury severity (d=0.46) and higher in those with NSSI than controls (d=0.37); effects varied by measurement instrument, with neurocognitive tasks non-significant (d=0.11).
Meta-analysisn = 69,572
Wang et al. Measuring impulsivity differently yields different answers: A three-level meta-analysis of associations between impulsivity and adolescent non-suicidal self-injuryMeta-analysis of 62 retrospective cohorts (29,709 patients, 209 models): machine learning discriminated intracranial aneurysm rupture status better than PHASES (testing AUC 0.837 vs 0.646) and regression (0.806), but external validation specificity fell to 0.66.
Meta-analysisn = 29,709
Patel et al. Diagnostic performance of machine learning models versus established risk stratification for intracranial aneurysm rupture: a systematic review and bivariate meta-analysisMeta-analysis of 10 RCTs (n=29,232) in ACS patients undergoing PCI: ultrashort (≤1 month) vs standard DAPT did not increase MACCE (HR 1.06, 95% CI 0.93-1.20) and reduced major bleeding (HR 0.47); MACCE was higher in STEMI and with ≤1-week DAPT.
Meta-analysisn = 29,232
Hendrianus et al. Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI: A Meta-AnalysisMeta-analysis of 3 RCTs (14,239 patients) after noncardioembolic ischaemic stroke or TIA: FXIa inhibitors added to antiplatelets vs placebo cut any stroke (RR 0.75) without a clear rise in major bleeding (RR 1.12, 95% CI 0.87-1.44). Results driven by one phase 3 trial.
Meta-analysisn = 14,239
Katsanos et al. Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-AnalysisInterim analysis: in 10,799 patients with high-risk adenomas, first surveillance colonoscopy at 5 vs 3 years after polypectomy was noninferior for 5-year colorectal cancer incidence (0.77% vs 0.82%; difference −0.05 points; upper CI bound 0.68, margin 0.7).
RCTn = 10,799
Jover et al. Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma RemovalBayesian network meta-analysis of 8 RCTs (10 644 patients with HFpEF/HFmrEF): only finerenone reduced HF hospitalisation vs placebo (RR 0.84); spironolactone and eplerenone were non-significant; no MRA reduced CV death; finerenone and spironolactone increased hyperkalaemia.
Meta-analysisn = 10,644
Bagattoli et al. Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safetyMeta-analysis of 39 RCTs (8399 adults with cancer): early palliative care (within 12 weeks of diagnosis or first-line treatment) versus standard care improved quality of life (SMD 0.30); an exploratory survival benefit was seen (HR 0.84), to be interpreted with caution.
Meta-analysisn = 8,399
Long et al. Integration of early palliative care in cancer treatment: a meta-analysis of 39 randomized controlled trials on clinical outcomes and management optimization